Spermidine vs. Urolithin A vs. NMN: What’s the Difference?

Medical disclaimer: This article is for informational purposes only and is not medical advice. Individual results vary. Consult a healthcare professional before starting any supplement, especially if you take other medications or have a liver, kidney, heart, or thyroid condition. Claims that any supplement “reverses” or “slows” aging are not scientifically established in humans and should be treated with skepticism.

Spermidine and urolithin A are two of the newer names in the longevity supplement world, often mentioned in the same breath as NMN and NAD+ boosters, and sometimes marketed as if they all do the same thing. They do not. Each targets a different piece of the aging-cell puzzle, and each has a different, honestly modest, level of human evidence behind it. Here is a straightforward look at how spermidine, urolithin A, and NMN actually differ, and what the research does and does not support for each one.

What Are Spermidine, Urolithin A, and NMN? Three Different Pathways

These three ingredients get lumped together as “longevity supplements,” but they work through genuinely different biological processes:

• Spermidine is a naturally occurring polyamine found in wheat germ, soybeans, aged cheese, mushrooms, and other foods, and your body also produces some on its own. Research interest centers on its role in triggering autophagy, the cell’s internal cleanup process that clears out damaged proteins and worn-out cell parts.
• Urolithin A is not something you eat directly in meaningful amounts. It is a metabolite that gut bacteria produce after you eat foods containing ellagitannins, such as pomegranates, walnuts, and certain berries. How much urolithin A any one person’s gut produces from those foods varies enormously based on their individual gut microbiome, some people are efficient “producers” and others make very little regardless of diet. That variability is the reason direct urolithin A supplements exist: they are marketed as a way to get a consistent dose without depending on your gut bacteria to make it for you. Research on urolithin A centers on mitophagy, the selective clearing of damaged mitochondria (the cell’s energy-producing structures).
• NMN (nicotinamide mononucleotide) works differently again: it is a direct precursor to NAD+, a coenzyme every cell needs for energy production and DNA repair, and one that reliably declines with age. Taking NMN is intended to replenish that raw material rather than trigger a cleanup process. See our full NMN & Nicotinamide Riboside guide for the complete picture on NMN specifically.

In short: spermidine targets autophagy, urolithin A targets mitophagy (a specific, mitochondria-focused type of autophagy), and NMN targets NAD+ levels directly. All three sit within the broader field of mitochondrial and cellular-aging research, but they are not interchangeable, and taking one does not substitute for what the others are studied for.

Evidence-Based Look: What Human Research Actually Shows

Spermidine

The most rigorous human trial to date is a 12-month, placebo-controlled randomized trial in 100 older adults with subjective cognitive decline, using a low daily dose (0.9 mg) of spermidine from wheat germ extract. It found no statistically significant improvement in memory performance compared with placebo (treatment effect −0.03, 95% CI −0.11 to 0.05, P = .47), and no significant change in secondary biomarkers. The study authors noted the dose tested may have been too low and the trial may have been too short to detect an effect.

Separately, larger population studies (not supplement trials) have found that people with higher dietary spermidine intake, from food, over many years, tend to have lower all-cause and cardiovascular mortality risk in observational data. That is a real, published finding, but it is correlational: it describes a dietary pattern over a lifetime, not the effect of taking a spermidine supplement, and it cannot be assumed to transfer to short-term supplementation.

Urolithin A

Randomized, placebo-controlled human trials (roughly 4 months, around 500 mg/day) in middle-aged and older adults have reported statistically significant improvements in muscle endurance and in biomarkers of mitochondrial health compared with placebo. This is a more consistent positive signal on a measurable physical outcome than spermidine’s trial record. An important caveat: a substantial share of this research has been funded by the company that manufactures and sells the branded urolithin A ingredient used in the studies, which does not invalidate the findings but is worth knowing when weighing the evidence. No human trial has shown urolithin A extends lifespan or reverses a disease of aging.

NMN

NMN’s human evidence follows the same pattern described in our dedicated NMN & Nicotinamide Riboside guide: small human trials reliably show it raises blood NAD+ levels, with some inconsistent secondary findings on metabolic or muscle markers, but no completed human trial has shown a translated longevity or disease-prevention benefit. See our NMN vs Resveratrol comparison for how NMN stacks up against another widely marketed longevity ingredient.

Across all three, the pattern is consistent: real, active areas of research with some genuinely interesting mechanistic and short-term biomarker data, and zero completed human trials demonstrating that any of them slows aging, reverses aging, or extends human lifespan. Marketing claims that go further than this are outrunning the evidence.

Dosage Guide

• Spermidine: Human trials have used doses ranging from roughly 0.9 mg/day (wheat germ extract, the dose used in the 12-month RCT above) up to several milligrams per day in shorter, smaller studies. No official Tolerable Upper Intake Level has been established.
• Urolithin A: The trials showing improvements in muscle endurance and mitochondrial biomarkers used roughly 500 mg to 1,000 mg per day.
• NMN: Commonly studied at 250 to 900 mg per day. See the NMN & Nicotinamide Riboside guide for full dosing detail, including NR (nicotinamide riboside).
• Timing: All three are typically taken once daily in published trial protocols, most often in the morning.

Cost and Practical Considerations

Pricing varies considerably by brand, dose, and formulation, so treat the following as general positioning rather than fixed numbers: spermidine (wheat germ extract) products tend to sit at the lower end of the three price-wise, NMN typically falls in the middle, and branded urolithin A products tend to be the most expensive of the three on a per-month basis, in part because it is manufactured and marketed as a proprietary ingredient rather than sold as a simple extract. None of the three is inexpensive as “just try it” purchases go, which is one more reason to be skeptical of sweeping benefit claims before spending money on any of them.

Safety & Interactions

Short-term human trials of all three ingredients have generally reported good tolerability, with occasional mild digestive upset. Long-term, multi-year human safety data is limited for all three simply because this is a recent area of widespread human supplementation.

• Spermidine is a compound your body already produces and consumes as part of a normal diet, so dietary-level intake is generally considered safe; supplement-dose, long-term safety specifically has less established data.
• Urolithin A has been generally well tolerated in the trials conducted so far; because it is newer to the market, choosing a brand that publishes third-party purity and potency testing is worth prioritizing.
• NMN carries the same cautions detailed in our Is NMN Safe to Take Long Term? guide, including a recommendation that anyone in active cancer treatment talk to their oncologist first, since NAD+, and by extension the broader mitochondrial-health pathways spermidine and urolithin A also touch, supports cellular metabolism broadly.

No human trial has tested spermidine, urolithin A, and NMN together as a combined “stack.” If you are considering taking more than one, especially alongside other medications or a history of cancer, talk to a doctor first rather than assuming that combining research-backed ingredients simply adds their individual effects together.

Bottom Line

Spermidine, urolithin A, and NMN are three distinct compounds studied through three distinct mechanisms, autophagy, mitophagy, and NAD+ repletion, all within the genuinely active field of mitochondrial and cellular-aging research. None of the three has been shown in a completed human trial to reverse aging, slow aging, or extend human lifespan. Of the three, urolithin A currently has the most consistent short-term human trial data on a measurable outcome (with an industry-funding caveat worth knowing), NMN reliably raises NAD+ without a proven downstream longevity benefit yet, and spermidine’s largest and longest human trial to date found no significant cognitive benefit at the dose tested. Treat “longevity supplement” marketing claims for any of the three with the same healthy skepticism, regardless of which one is being sold.

Frequently Asked Questions

Q: Should I take spermidine, urolithin A, and NMN together?

A: No human trial has tested this specific three-ingredient combination, so there is no evidence base for or against stacking all three. If you want to try more than one, discuss it with a doctor first, especially if you take other medications or have a history of cancer.

Q: Does any of these reverse aging?

A: No. None of the three has been shown in a human trial to reverse aging or extend human lifespan. That framing comes from animal studies or marketing, not from established human clinical evidence.

Q: Which of the three has the strongest human evidence?

A: Of the three, urolithin A currently has the most consistent short-term human trial data on a measurable outcome (muscle endurance and mitochondrial biomarkers), though a meaningful share of that research has been funded by the company that sells the branded ingredient. Spermidine’s most rigorous trial to date, a 12-month study in older adults, found no significant cognitive benefit. NMN reliably raises NAD+ levels but has not yet shown a translated human longevity benefit.

Q: Why don’t some people get urolithin A from food alone?

A: Urolithin A is produced when gut bacteria convert compounds called ellagitannins, found in foods like pomegranates, walnuts, and berries, into urolithin A. How efficiently any one person’s gut microbiome does this varies widely, some people convert very little regardless of how much of those foods they eat, which is the rationale behind marketing urolithin A as a direct supplement rather than relying on food conversion.

Related Reading

• NMN & Nicotinamide Riboside: Benefits, Dosage, Best Forms & Safety
• NMN vs Resveratrol: Which Longevity Ingredient Has Stronger Evidence?
• Is NMN Safe to Take Long Term?
• Top 5 Anti-Aging Supplements 2026, Ranked & Compared

Sources

• NIH National Institute on Aging: research briefs on NAD+ and cellular aging
• JAMA Network Open: Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline, A Randomized Clinical Trial (PMC9136623)
• PubMed: Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults, A Randomized Clinical Trial (PMID 35050355)
• PubMed: Urolithin A Improves Muscle Strength, Exercise Performance, and Biomarkers of Mitochondrial Health in a Randomized Trial in Middle-Aged Adults (PMID 35584623)
• European Journal of Clinical Nutrition: Direct Supplementation With Urolithin A Overcomes Limitations of Dietary Exposure and Gut Microbiome Variability in Healthy Adults
• NIH Office of Dietary Supplements background materials